Tekna, a global leader in advanced material solutions for industry, has been awarded a significant contract worth 1.5 million Canadian dollars for titanium powder used exclusively for medical applications.
The contract covers the supply of Tekna’s main grade of titanium alloy powder used exclusively for medical purposes and is scheduled for the first three quarters of 2024. This represents a remarkable 60% year-on-year increase in orders from this customer and is part of a three-year distribution agreement. The customer is a leading distributor of titanium powder and holds a significant position in the medical and dental industry in Europe and worldwide. This partnership not only expands Tekna’s footprint but also strengthens its influence in the global market.
“This substantial order is a testament to Tekna’s growing influence and reputation in the advanced materials industry, particularly in the medical sector, which has grown to become one of the most advanced and prominent users of additive manufacturing on a global scale. Partnering with a key player in the European market not only strengthens our position but also highlights the trust and reliability associated with our products. We are proud to play a pivotal role in advancing medical technologies through our specialized titanium powders,” said Luc Dionne, CEO of Tekna.
This agreement underlines Tekna’s commitment to excellence and innovation in advanced materials and its dedication to meeting the increasing demands of the medical sector. With this new agreement, Tekna continues to strengthen its position as a key supplier of specialized materials on a global scale. Tekna’s quality management system is ISO 13485:2016 certified for medical applications.